MRAM vs SLAB: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

SLAB is the larger of the two ($7.38B market cap): the incumbent the market prices for continued execution (50.74x forward earnings, beta 1.21). MRAM is the smaller challenger ($311.33M), cheaper on forward earnings (22.17x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

MRAM vs SLAB: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricMRAMSLABWhat it tells you
Market cap$311.33M$7.38BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E22.1750.74Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Beta2.191.21Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range12% of range98% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book4.606.74How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: MRAM is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how MRAM and SLAB affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MRAM and SLAB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MRAM and SLAB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Everspin Technologies (MRAM) do?

Everspin Technologies, based in Chandler, Arizona, builds magnetoresistive random access memory and the tunnel magnetoresistance sensors that share its magnetic process. Its memory stores each bit in a magnetic tunnel junction rather than a charge trap, so data survives a power cut, writes complete in nanoseconds, endurance is effectively unlimited, and radiation does not corrupt the cell. Those properties put the parts where flash struggles: write buffers in industrial automation controllers, smart meters and energy management gear, transportation systems, RAID cache in storage arrays, and aerospace and defense hardware where a boot image cannot be allowed to fail. Two product families carry the business, the older Toggle MRAM and the newer spin-transfer torque line sold as PERSYST, alongside a portfolio of more than 700 patents and applications. Manufacturing is split: Everspin buys standard CMOS wafers and adds its own magnetic layers at a 200mm fab it operates in Chandler, while GlobalFoundries produces full-flow 300mm STT-MRAM wafers under a long-standing agreement that grants GlobalFoundries exclusivity on certain nodes for a period after qualification.

Full MRAM guide

What does Silicon Laboratories (SLAB) do?

Silicon Laboratories, or Silicon Labs, is an Austin-based semiconductor company focused on wireless connectivity for the Internet of Things. After selling its Infrastructure and Automotive business to Skyworks Solutions in 2021, it became a pure-play IoT connectivity designer. Its chips (wireless SoCs, microcontrollers, and modules, paired with software stacks and its Simplicity Studio development tools) support Bluetooth, Zigbee, Z-Wave, Thread, Matter, Wi-Fi, and proprietary protocols. The company reports in two segments: Industrial & Commercial, which serves smart buildings, metering, industrial automation, and connected commercial devices, and Home & Life, which serves smart-home, consumer, and connected-health products. Its differentiator is multi-protocol SoCs that give developers flexibility across standards, competing against players like Nordic Semiconductor, NXP, Espressif, and Microchip.

Full SLAB guide

MRAM vs SLAB: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • MRAM drivers: Defense and space work that sells process, not just parts; A density roadmap aimed at edge AI and servers.
  • SLAB drivers: Pending Texas Instruments acquisition; Deal timeline and regulatory approval.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The most consequential open item is litigation, and it is a patent fight rather than a shareholder suit: Avalanche Technology filed a patent infringement complaint against Everspin in the US District Court for the District of Delaware and a parallel Section 337 complaint on January 28, 2026, amended February 5, and the International Trade Commission voted to institute Investigation No. For SLAB, the central risk is specific to the pending acquisition: if the Texas Instruments deal is delayed, renegotiated, or fails to receive regulatory approval (shareholders already approved it in April 2026), the stock could fall back toward its pre-deal level, well below $231; the 52-week low was ~$115.51.

MRAM or SLAB: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MRAM if you believe its drivers more; SLAB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MRAM and SLAB guides.

MRAM vs SLAB: the full fundamentals

MRAM. Everspin is one of those companies where the GAAP and non-GAAP lines tell different stories: stock compensation and litigation expense produced a ~$3.6 million GAAP loss in the same quarter that generated ~$2.9 million of non-GAAP income on record revenue. After the stock fell to $13.44 by October 16, 2026, trailing revenue near ~$62.5 million against a ~$327 million market value works out to roughly 5.2 times sales, and the forward P/E sits near 27. The September-quarter report on October 28 (consensus ~$20.1 million and ~$0.12 per share) is the next read on whether the sequential run and the $40 million prime-contract work keep compounding.

SLAB. Figures are approximate and tied to the asOf date; verify live numbers before acting. Because of the all-cash acquisition, traditional valuation multiples (the stock shows ~51x forward earnings) matter less than the fixed $231 offer price and the odds and timing of the deal closing. At ~$221.23 on October 16, 2026 the shares trade about 4.4% below $231, and that gap reflects the market's estimate of regulatory risk plus a wait of up to roughly eight months until closing. If the deal were to fall through, the shares would likely re-rate toward standalone fundamentals, which are more cyclical and lower than the offer implies.

Headline figures (approximate, October 2026): MRAM shows revenue (ttm) ~$62.5M, q2 2026 revenue ~$18.7M, a company record, up ~42% year over year, gross margin (ttm) ~52.3% (Q2 2026: ~53.9%), q2 2026 earnings per share ~-$0.15 GAAP, ~$0.11 non-GAAP vs ~$0.09 consensus; SLAB shows acquisition price $231.00 per share in cash from Texas Instruments (announced Feb 4, 2026; approximately $7.5 billion enterprise value), deal status Shareholders approved April 30, 2026; close expected first half of 2027, pending regulatory approvals, share price and spread (oct 16, 2026) ~$221.23, about $9.77 (~4.4%) below the offer; market cap ~$7.4 billion, revenue (ttm) ~$856 million; Q2 2026 ~$228 million, up ~18% year over year.

The bottom line: MRAM vs SLAB

MRAM and SLAB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MRAM and SLAB exposure against your real portfolio. It is not an investment adviser.

Wondering how MRAM or SLAB fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Everspin Technologies

Ask Walnut's AI anything about MRAM and see how it fits what you own.

FAQ

What is the difference between MRAM and SLAB?

+

Everspin Technologies, based in Chandler, Arizona, builds magnetoresistive random access memory and the tunnel magnetoresistance sensors that share its magnetic process. Silicon Laboratories, or Silicon Labs, is an Austin-based semiconductor company focused on wireless connectivity for the Internet of Things. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is MRAM or SLAB the better stock?

+

Neither is universally better. SLAB is the larger incumbent; MRAM is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, MRAM or SLAB?

+

On forward P/E (as of November 2026), MRAM trades at 22.17x and SLAB at 50.74x, so MRAM is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both MRAM and SLAB?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of MRAM vs SLAB?

+

MRAM: The most consequential open item is litigation, and it is a patent fight rather than a shareholder suit: Avalanche Technology filed a patent infringement complaint against Everspin in the US District Court for the District of Delaware and a parallel Section 337 complaint on January 28, 2026, amended February 5, and the International Trade Commission voted to institute Investigation No. 337-TA-1487 on February 27, 2026 before Administrative Law Judge Doris Johnson Hines, asserting 37 claims across four patents and requesting an exclusion order plus a cease and desist order that would bar importation of Everspin's STT-MRAM products. Everspin has stated the claims reach the STT-MRAM line only and not Toggle MRAM or sensor devices, and that it believes it has strong defenses and will contest them; a Section 337 investigation typically concludes 14 to 16 months from institution, so resolution is unlikely before roughly mid-2027, and defense costs are one reason the GAAP loss widened to ~$3.6 million in a quarter when revenue and gross margin both improved. Beyond the case, revenue is small and lumpy, a handful of industrial and defense customers and one prime-contract agreement account for a meaningful share of it, and wafer supply depends on GlobalFoundries under an arrangement that grants exclusivity on certain STT-MRAM nodes. Valuation carries its own exposure, since ~5.2 times trailing sales with GAAP losses already prices the data-center and defense roadmap converting rather than merely being demonstrated, and the trading character compounds it: the shares have ranged from $7.35 to $51.50 within twelve months and closed at $13.44 on October 16, 2026, a leveraged single-stock ETF now trades against them, and realised volatility of that order is not proportional to changes in the underlying business. Walnut is not an investment adviser. SLAB: The central risk is specific to the pending acquisition: if the Texas Instruments deal is delayed, renegotiated, or fails to receive regulatory approval (shareholders already approved it in April 2026), the stock could fall back toward its pre-deal level, well below $231; the 52-week low was ~$115.51. Antitrust and foreign-investment reviews across multiple jurisdictions add uncertainty, and the expected first-half-2027 close means capital is tied up for an extended period with only the fixed cash payout as upside, so the return is capped even if the business outperforms. Because guidance is suspended, investors have less visibility into current trading than usual. If the deal did break, standalone Silicon Labs would again face its normal risks: cyclical IoT chip demand, inventory swings at distributors and customers, intense competition from Nordic Semiconductor and others, customer concentration, and the general volatility of a mid-cap semiconductor stock. There is also opportunity cost, since the money could sit near a fixed price for many months. Anyone buying now should understand they are largely making a bet on deal completion and timing, not on Silicon Labs' long-term growth.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell MRAM or SLAB; figures are approximate and dated (as of November 2026). Verify current data before investing.